New calcium ingredient with improved flow and compactability properties
At this year’s CPhI Worldwide, mineral producer Omya will launch its new Calcipur® DC range,...
Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into...
Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled...
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will...
FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment of Select Patients with TGCT...
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO™ (pexidartinib) as the first...
LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples
LexaGene Holdings, Inc, a biotechnology company that develops genetic analyzers for pathogen detection and other...
Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential
Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a...
A Powerful Pairing: Academia-Industry Collaborations for Pharmaceutical Innovation
Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been...
New state of the art cleanroom completed by WHP for ADC bio
Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted...
Pathogen engineered to self destruct underlies cancer vaccine platform
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as...
Artificial DNA can control release of active ingredients from drugs
A drug with three active ingredients that are released in sequence at specific times: Thanks...
